GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (OTCPK:SARTF) » Definitions » Cyclically Adjusted PS Ratio

Sartorius AG (Sartorius AG) Cyclically Adjusted PS Ratio : 6.09 (As of Apr. 28, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sartorius AG Cyclically Adjusted PS Ratio?

As of today (2024-04-28), Sartorius AG's current share price is $248.00. Sartorius AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $40.70. Sartorius AG's Cyclically Adjusted PS Ratio for today is 6.09.

The historical rank and industry rank for Sartorius AG's Cyclically Adjusted PS Ratio or its related term are showing as below:

SARTF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.75   Med: 9.28   Max: 33.28
Current: 6.08

During the past years, Sartorius AG's highest Cyclically Adjusted PS Ratio was 33.28. The lowest was 4.75. And the median was 9.28.

SARTF's Cyclically Adjusted PS Ratio is ranked worse than
75.05% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs SARTF: 6.08

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sartorius AG's adjusted revenue per share data for the three months ended in Mar. 2024 was $12.865. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $40.70 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sartorius AG Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Sartorius AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Cyclically Adjusted PS Ratio Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.34 16.43 19.33 10.52 7.26

Sartorius AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.47 7.47 7.40 7.26 7.37

Competitive Comparison of Sartorius AG's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Sartorius AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Cyclically Adjusted PS Ratio falls into.



Sartorius AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Sartorius AG's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=248.00/40.7
=6.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Sartorius AG's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=12.865/123.6675*123.6675
=12.865

Current CPI (Mar. 2024) = 123.6675.

Sartorius AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 4.405 99.543 5.473
201409 4.205 99.823 5.209
201412 4.487 99.543 5.574
201503 4.067 99.717 5.044
201506 4.594 100.417 5.658
201509 4.891 100.417 6.023
201512 4.569 99.717 5.666
201603 4.842 100.017 5.987
201606 14.607 100.717 17.936
201609 5.528 101.017 6.768
201612 5.226 101.217 6.385
201703 5.242 101.417 6.392
201706 5.828 102.117 7.058
201709 5.960 102.717 7.176
201712 6.502 102.617 7.836
201803 6.428 102.917 7.724
201806 6.738 104.017 8.011
201809 6.763 104.718 7.987
201812 6.961 104.217 8.260
201903 7.163 104.217 8.500
201906 7.576 105.718 8.862
201909 7.424 106.018 8.660
201912 7.703 105.818 9.002
202003 8.224 105.718 9.620
202006 9.084 106.618 10.537
202009 10.756 105.818 12.570
202012 11.700 105.518 13.712
202103 13.663 107.518 15.715
202106 14.724 108.486 16.785
202109 15.385 109.435 17.386
202112 15.233 110.384 17.066
202203 16.460 113.968 17.861
202206 15.978 115.760 17.069
202209 15.213 118.818 15.834
202212 16.440 119.345 17.035
202303 14.126 122.402 14.272
202306 13.189 123.140 13.245
202309 13.079 124.195 13.023
202312 13.544 123.668 13.544
202403 12.865 123.668 12.865

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sartorius AG  (OTCPK:SARTF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Sartorius AG Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG (Sartorius AG) Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Sartorius AG (Sartorius AG) Headlines

From GuruFocus

Sartorius Raises Forecast for the Full Year of 2020

By PRNewswire PRNewswire 07-16-2020

Sartorius closes acquisition of BIA Separations

By PRNewswire PRNewswire 11-02-2020

Change in Composition of Sartorius Joint Heirship

By PRNewswire PRNewswire 10-13-2021

Resolutions of the Supervisory Board of Sartorius AG

By PRNewswire PRNewswire 02-11-2021

Strong profitable growth at Sartorius

By PRNewswire PRNewswire 10-20-2020

Sartorius significantly expands activities in South Korea

By PRNewswire PRNewswire 11-25-2021

Sartorius with first-quarter uptick in sales and earnings

By PRNewswire PRNewswire 04-21-2021